Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
| Data(s) |
2012
|
|---|---|
| Resumo |
The efficacy of durable polymer drug-eluting stents (DES) is delivered at the expense of delayed healing of the stented vessel. Biodegradable polymer DES aim to avoid this shortcoming and may potentially improve long-term clinical outcomes, with benefit expected to accrue over time. We sought to compare long-term outcomes in patients treated with biodegradable polymer DES vs. durable polymer sirolimus-eluting stents (SES). |
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/7367/1/Stefanini%20EurHeartJ%202012.pdf Stefanini, Giulio G; Byrne, Robert A; Serruys, Patrick W; de Waha, Antoinette; Meier, Bernhard; Massberg, Steffen; Jüni, Peter; Schömig, Albert; Windecker, Stephan; Kastrati, Adnan (2012). Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. European Heart Journal, 33(10), pp. 1214-22. Oxford: Oxford University Press 10.1016/S0735-1097(12)60286-1 <http://dx.doi.org/10.1016/S0735-1097(12)60286-1> doi:10.7892/boris.7367 info:doi:10.1016/S0735-1097(12)60286-1 info:pmid:22447805 urn:issn:0195-668X |
| Idioma(s) |
eng |
| Publicador |
Oxford University Press |
| Relação |
http://boris.unibe.ch/7367/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Stefanini, Giulio G; Byrne, Robert A; Serruys, Patrick W; de Waha, Antoinette; Meier, Bernhard; Massberg, Steffen; Jüni, Peter; Schömig, Albert; Windecker, Stephan; Kastrati, Adnan (2012). Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. European Heart Journal, 33(10), pp. 1214-22. Oxford: Oxford University Press 10.1016/S0735-1097(12)60286-1 <http://dx.doi.org/10.1016/S0735-1097(12)60286-1> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |
